-
Assessing the Cost-Effectiveness of Subcutaneous Semaglutide 2.4 mg in the Management of Individuals With Obesity and Prediabetes in England
Sep 9, 2025, 16:22 PM -
Lifetime Secondary Healthcare Resource Utilization in Phenylketonuria From Birth to Adulthood in Sweden
Sep 9, 2025, 16:22 PM -
Clinical and Economic Burden Imposed by Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM) in Belgium
Sep 9, 2025, 16:22 PM -
APDS Treatment in Germany: Decision Criteria, Costs, and Contribution of Leniolisib to Outcomes
Sep 9, 2025, 16:22 PM -
Transplant Eligibility in DLBCL: A Real-World Analysis of German Hospital Billing Data
Sep 9, 2025, 16:22 PM -
Societal and Economic Impact of Long-Acting Injectable Buprenorphine (LAIB) Compared With Standard Opioid Substitution Therapy (OST) in France
Sep 9, 2025, 16:22 PM -
Evaluation of the Measurement Properties of the German LupusPRO™ for Swiss-German SLE Patients
Sep 9, 2025, 16:22 PM -
Evaluation of the Societal Impact of Emicizumab in France Since Its Market Authorization: Budget Impact From 2018 to 2024
Sep 9, 2025, 16:22 PM -
Variability in Health Utility Scores in Pancreatic Cancer: Findings From a Targeted Literature Review
Sep 9, 2025, 16:22 PM -
Statistical Analysis of Health Technology Assessment Outcomes in Oncology: An Analysis of Key Clinical Value Drivers in Germany and France
Sep 9, 2025, 16:22 PM -
Orphan Drugs Availability in Israel: A Base for Policy Development
Sep 9, 2025, 16:22 PM -
Characteristics of Real-World Data Landscape in Spain: A Scoping Review
Sep 9, 2025, 16:22 PM -
Simulating Patient Journeys in Heart Failure to Optimize Treatment Pathways: An Agent-Based Modeling Study
Sep 9, 2025, 16:22 PM -
Mind the Gap: Exploring Variation in Guidelines for Indirect Treatment Comparison (ITC) Across Europe
Sep 9, 2025, 16:22 PM -
From Methods to Decisions: A Transparent Framework for Population-Adjusted Treatment Comparisons
Sep 9, 2025, 16:22 PM -
Assessing the Potential Impact of NICE’s Updated HST Routing Criteria on Ultraorphan Drugs
Sep 9, 2025, 16:22 PM -
The Economic Burden of Acromegaly Disease in the Kingdom of Saudi Arabia
Sep 9, 2025, 16:22 PM -
Leveraging Large Language Models and EMR Data to Identify Undiagnosed Rare Diseases: A Hybrid AI Approach
Sep 9, 2025, 16:22 PM -
A Systematic Review and Network Meta Analysis of Pharmacologic Disease-Modifying Therapies for Early Alzheimer's Disease
Sep 9, 2025, 16:22 PM -
Disease Severity at Advanced Therapy Initiation in Real-World Psoriasis Patients in the US
Sep 9, 2025, 16:22 PM